Author:
Pochon Cécile,Courbon Corinne,Bay Jacques-Olivier,Moreau Anne-Sophie,Paul Franciane,Picard Muriel,Sterin Arthur,Tudesq Jean-Jacques,Vicente Céline,Yakoub-Agha Mathilde,Yakoub-Agha Ibrahim
Subject
Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine
Reference30 articles.
1. Medium-term follow-up of patients treated with chimeric antigen receptor T cells (CART cells): recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC);Alsuliman;Bull Cancer,2021
2. Tisagenlecleucel in pediatric patients with acute lymphoblastic leukemia;Maude SL:;Clin Adv Hematol Oncol,2018
3. Tisagenlecleucel in adult relapsed or refractory diffuse large B-Cell lymphoma;Schuster;N Engl J Med,2019
4. Real world experience of approved chimeric antigen receptor T-cell therapies outside of clinical trials;Yassine;Curr Res Transl Med,2020
5. Treatment with anti-CD19 chimeric antigen receptor T cells after antibody-based immunotherapy in adults with acute lymphoblastic leukemia;Danylesko;Curr Res Transl Med,2019
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献